Cargando…
Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi‐center, open‐label, 52‐week phase 3 trial
Intravenous immunoglobulin (IVIg) therapy is currently the only established treatment in patients with multifocal motor neuropathy (MMN), and many patients have an IVIg‐dependent fluctuation. We aimed to investigate the efficacy and safety of every 3 week IVIg (1.0 g/kg) for 52 weeks. This study was...
Autores principales: | Kuwabara, Satoshi, Misawa, Sonoko, Mori, Masahiro, Iwai, Yuta, Ochi, Kazuhide, Suzuki, Hidekazu, Nodera, Hiroyuki, Tamaoka, Akira, Iijima, Masahiro, Toda, Tatsushi, Yoshikawa, Hiroo, Kanda, Takashi, Sakamoto, Ko, Kusunoki, Susumu, Sobue, Gen, Kaji, Ryuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033107/ https://www.ncbi.nlm.nih.gov/pubmed/29635876 http://dx.doi.org/10.1111/jns.12268 |
Ejemplares similares
-
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial
por: Kuwabara, Satoshi, et al.
Publicado: (2017) -
CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy
por: Furukawa, Takahiro, et al.
Publicado: (2015) -
Multifocal nodular hypertrophy of trigeminal nerve in multifocal acquired demyelinating sensory and motor neuropathy
por: Kuwahara, Motoi, et al.
Publicado: (2019) -
Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial
por: Katayama, Kanako, et al.
Publicado: (2015) -
Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis
por: Iwai, Yuta, et al.
Publicado: (2016)